{"id":2247,"date":"2021-11-23T00:00:00","date_gmt":"2021-11-23T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2247"},"modified":"2021-11-23T00:00:00","modified_gmt":"2021-11-23T00:00:00","slug":"centogene%e6%89%a9%e5%a4%a7%e4%b8%8eagios%e7%9a%84%e5%90%88%e4%bd%9c%ef%bc%8c%e4%bb%a5%e6%9c%9f%e5%9c%a8%e7%bd%95%e8%a7%81%e8%a1%80%e6%b6%b2%e7%96%be%e7%97%85%e9%a2%86%e5%9f%9f%e8%8e%b7%e5%be%97","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/zh\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/","title":{"rendered":"Centogene\u6269\u5927\u4e0eAgios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u89c1\u8840\u6db2\u75be\u75c5\u9886\u57df\u83b7\u5f97\u65b0\u7684\u89c1\u89e3"},"content":{"rendered":"

\u7f8e\u56fd\u9a6c\u8428\u8bf8\u585e\u5dde\u5251\u6865\u3001\u5fb7\u56fd\u7f57\u65af\u6258\u514b\u548c\u67cf\u6797\uff0c2021\u5e7411\u67084\u65e5\uff08GLOBE NEWSWIRE\uff09\u2014\u2014\u4e13\u6ce8\u4e8e\u5229\u7528\u6570\u636e\u9a71\u52a8\u6d1e\u5bdf\u8bca\u65ad\u3001\u7406\u89e3\u548c\u6cbb\u7597\u7f55\u89c1\u75c5\u7684\u5546\u4e1a\u5316\u9636\u6bb5\u516c\u53f8Centogene NV\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aCNTG\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u5df2\u6269\u5927\u4e0eAgios Pharmaceuticals, Inc.\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aAGIO\uff09\u7684\u5408\u4f5c\u3002Agios Pharmaceuticals, Inc.\u662f\u7ec6\u80de\u4ee3\u8c22\u9886\u57df\u7684\u9886\u5bfc\u8005\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u548c\u63d0\u4f9b\u9488\u5bf9\u57fa\u56e0\u660e\u786e\u75be\u75c5\u7684\u521b\u65b0\u7597\u6cd5\u3002\u6839\u636e\u65b0\u534f\u8bae\uff0cCENTOGENE\u5c06\u4e3aAgios\u7684\u4e09\u9879\u5168\u7403\u5173\u952e\u6027\u8bd5\u9a8c\u63d0\u4f9b\u57fa\u56e0\u68c0\u6d4b\u548c\u4e34\u5e8a\u8bd5\u9a8c\u652f\u6301\uff0c\u8fd9\u4e9b\u8bd5\u9a8c\u5206\u522b\u9488\u5bf9\u5730\u4e2d\u6d77\u8d2b\u8840\u548c\u9570\u72b6\u7ec6\u80de\u8d2b\u8840\u3002\u6b64\u524d\uff0cCENTOGENE\u5df2\u4e3aAgios\u7684\u4e19\u916e\u9178\u6fc0\u9176\uff08\u2019PK\u2019\uff09\u7f3a\u4e4f\u75c7\u4e34\u5e8a\u9879\u76ee\u63d0\u4f9b\u652f\u6301\u3002.<\/p>\n

\u53cc\u65b9\u7b7e\u7f72\u4e86\u4e00\u4efd\u4e3a\u671f\u4e09\u5e74\u7684\u5546\u4e1a\u670d\u52a1\u4ed8\u8d39\u534f\u8bae\u3002Agios\u5c06\u8d1f\u8d23\u534f\u8c03\u5e76\u627f\u62c5\u76f8\u5173\u9879\u76ee\u7684\u8d39\u7528\uff1b\u66f4\u591a\u8d22\u52a1\u7ec6\u8282\u672a\u4e88\u62ab\u9732\u3002\u6b64\u6b21\u5408\u4f5c\u5c06\u4e3a\u60a3\u8005\u63d0\u4f9b\u57fa\u56e0\u68c0\u6d4b\u670d\u52a1\uff0c\u4ee5\u5e2e\u52a9\u8bc6\u522b\u81f4\u75c5\u7a81\u53d8\uff0c\u5305\u62ecHBA1\u3001HBA2\u548cHBB\u57fa\u56e0\u3002Agios\u7684\u5168\u7403\u4e34\u5e8a\u8bd5\u9a8c\u5c06\u5728\u5317\u7f8e\u3001\u6b27\u6d32\u3001\u4e2d\u4e1c\u548c\u5317\u975e\u3001\u4e9a\u592a\u4ee5\u53ca\u62c9\u4e01\u7f8e\u6d32\u62db\u52df\u60a3\u8005\u3002\u6837\u672c\u5c06\u4f7f\u7528CENTOGENE\u4e13\u6709\u7684CentoCard\u00ae\u8fdb\u884c\u5e72\u8840\u6591\u5206\u6790\u3002.<\/p>\n

\u8be5\u5408\u4f5c\u5173\u7cfb\u7684\u5173\u952e\u8d44\u4ea7\u662f CENTOGENE \u72ec\u7279\u7684\u4ee5\u7f55\u89c1\u75c5\u4e3a\u4e2d\u5fc3\u7684\u751f\u7269\u6570\u636e\u5e93\uff0c\u8be5\u6570\u636e\u5e93\u65e8\u5728\u52a0\u901f\u7cbe\u51c6\u8bca\u65ad\uff0c\u5e76\u4e0d\u65ad\u6df1\u5165\u4e86\u89e3\u5bfc\u81f4\u7f55\u89c1\u75c5\u7684\u9057\u4f20\u56e0\u7d20\u3002.<\/p>\n

\u201c\u51ed\u501f\u6211\u4eec\u5168\u7403\u9886\u5148\u7684\u7f55\u89c1\u75c5\u751f\u7269\u6570\u636e\u5e93\uff0c\u6211\u4eec\u662f\u7f55\u89c1\u75c5\u6cbb\u7597\u836f\u7269\u53d1\u73b0\u548c\u5f00\u53d1\u9886\u57df\u7684\u9996\u9009\u5408\u4f5c\u4f19\u4f34\u3002\u6211\u4eec\u4ee5\u6570\u636e\u4e3a\u9a71\u52a8\u7684\u6d1e\u5bdf\u529b\u80fd\u591f\u52a0\u901f\u4e34\u5e8a\u8bd5\u9a8c\u5e76\u964d\u4f4e\u5176\u98ce\u9669\uff0c\u201dCENTOGENE\u9996\u5e2d\u6267\u884c\u5b98Andrin Oswald\u533b\u5b66\u535a\u58eb\u8868\u793a\u3002\u201c\u7ed3\u5408CENTOGENE\u5728\u9057\u4f20\u5b66\u9886\u57df\u7684\u4e13\u4e1a\u77e5\u8bc6\u548c\u72ec\u7279\u7684\u5168\u7403\u6d1e\u5bdf\u529b\uff0c\u5c06\u6709\u52a9\u4e8e\u6211\u4eec\u66f4\u597d\u5730\u4e86\u89e3\u8fd9\u4e9b\u7f55\u89c1\u75c5\u7684\u75be\u75c5\u751f\u7269\u5b66\u3002\u6b64\u6b21\u5408\u4f5c\u5c06\u652f\u6301Agios\u516c\u53f8\u9996\u521b\u7684PK\u6fc0\u6d3b\u5242\u7684\u7814\u53d1\uff0c\u4f7f\u5176\u6210\u4e3a\u5730\u4e2d\u6d77\u8d2b\u8840\u548c\u9570\u72b6\u7ec6\u80de\u8d2b\u8840\u75c7\u7684\u6f5c\u5728\u7597\u6cd5\u3002\u8fd9\u4e24\u79cd\u75be\u75c5\u7684\u60a3\u8005\u7fa4\u4f53\u76ee\u524d\u90fd\u7f3a\u4e4f\u6cbb\u7597\u9009\u62e9\uff0c\u4e9f\u9700\u65b0\u7684\u6cbb\u7597\u65b9\u6848\u3002\u2019<\/p>\n

\u201c\u5c55\u671b\u4eca\u5e74\u5e74\u5e95\u524d\u542f\u52a8\u7684\u4e09\u9879\u9488\u5bf9\u5730\u4e2d\u6d77\u8d2b\u8840\u548c\u9570\u72b6\u7ec6\u80de\u75c5\u7684\u5173\u952e\u6027\u5168\u7403\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u6211\u4eec\u5f88\u9ad8\u5174\u80fd\u4e0eCENTOGENE\u6269\u5927\u5408\u4f5c\uff0c\u4ee5\u66f4\u597d\u5730\u4e86\u89e3\u6211\u4eec\u7814\u7a76\u4e2d\u60a3\u8005\u7684\u6f5c\u5728\u9057\u4f20\u56e0\u7d20\u4ee5\u53ca\u6211\u4eec\u6b63\u5728\u7814\u53d1\u7684\u836f\u7269\u7684\u6f5c\u5728\u5f71\u54cd\uff0c\u201dAgios\u9996\u5e2d\u533b\u7597\u5b98Sarah Gheuens\u533b\u5b66\u535a\u58eb\u8868\u793a\u3002\u201c\u5728Agios\uff0c\u6211\u4eec\u6df1\u77e5\u5353\u8d8a\u7684\u79d1\u5b66\u7814\u7a76\u9700\u8981\u4e16\u754c\u4e00\u6d41\u7684\u56e2\u961f\u5408\u4f5c\u3002\u901a\u8fc7\u4e0eCENTOGENE\u8fd9\u6837\u6770\u51fa\u7684\u5408\u4f5c\u4f19\u4f34\u643a\u624b\uff0c\u6211\u4eec\u53ef\u4ee5\u5171\u540c\u52a0\u901f\u521b\u65b0\uff0c\u4ece\u800c\u4e3a\u60a3\u8005\u7684\u751f\u6d3b\u5e26\u6765\u79ef\u6781\u7684\u6539\u53d8\u3002\u2019<\/p>\n

\u8be5\u534f\u8bae\u6807\u5fd7\u7740 CENTOGENE \u5728\u672a\u6765 10 \u5e74\u5185\u6cbb\u6108 100 \u79cd\u7f55\u89c1\u75be\u75c5\u7684\u4f7f\u547d\u53c8\u8fc8\u51fa\u4e86\u91cd\u8981\u4e00\u6b65\u3002. <\/p>\n

\u4e86\u89e3\u66f4\u591a<\/a><\/p>\n

\u5173\u4e8e\u5730\u4e2d\u6d77\u8d2b\u8840<\/h2>\n

\u5730\u4e2d\u6d77\u8d2b\u8840\u662f\u4e00\u79cd\u9057\u4f20\u6027\u8840\u6db2\u75be\u75c5\uff0c\u5728\u7f8e\u56fd\u3001\u6cd5\u56fd\u3001\u5fb7\u56fd\u3001\u610f\u5927\u5229\u3001\u897f\u73ed\u7259\u548c\u82f1\u56fd\uff08\u201c\u6b27\u76df\u4e94\u56fd\u201d\uff09\u7ea6\u670918,000\u81f323,000\u4eba\u60a3\u6709\u6b64\u75c5\uff0c\u4e16\u754c\u5176\u4ed6\u5730\u533a\u8fd8\u6709\u66f4\u591a\u60a3\u8005\u3002\u8840\u7ea2\u86cb\u767d\u57fa\u56e0\u7684\u9057\u4f20\u6027\u7a81\u53d8\u5bfc\u81f4\u4eba\u4f53\u4ea7\u751f\u7684\u8840\u7ea2\u86cb\u767d\u5c11\u4e8e\u6b63\u5e38\u6c34\u5e73\uff0c\u800c\u8840\u7ea2\u86cb\u767d\u5bf9\u4e8e\u7ea2\u7ec6\u80de\u643a\u5e26\u6c27\u6c14\u81f3\u5173\u91cd\u8981\uff0c\u56e0\u6b64\u4f1a\u5bfc\u81f4\u4e25\u91cd\u7684\u8d2b\u8840\u53ca\u76f8\u5173\u5e76\u53d1\u75c7\u3002.<\/p>\n

\u5730\u4e2d\u6d77\u8d2b\u8840\u5206\u4e3a\u03b2\u578b\u548c\u03b1\u578b\u4e24\u79cd\u3002\u4e24\u8005\u5747\u4e3a\u5e38\u67d3\u8272\u4f53\u9690\u6027\u9057\u4f20\uff0c\u5168\u7403\u7ea6\u670951%\u7684\u4eba\u53e3\u643a\u5e26\u03b2\u6216\u03b1\u73e0\u86cb\u767d\u57fa\u56e0\u7a81\u53d8\u3002\u90e8\u5206\u60a3\u8005\u9700\u8981\u957f\u671f\u8f93\u8840\uff0c\u8fd9\u53ef\u80fd\u5bfc\u81f4\u94c1\u8fc7\u8f7d\u53ca\u76f8\u5173\u5668\u5b98\u635f\u4f24\u7b49\u957f\u671f\u5e76\u53d1\u75c7\u3002\u5373\u4f7f\u65e0\u9700\u957f\u671f\u8f93\u8840\u7684\u60a3\u8005\uff0c\u4e5f\u53ef\u80fd\u51fa\u73b0\u80ba\u52a8\u8109\u9ad8\u538b\u548c\u8840\u6813\u5f62\u6210\u7b49\u4e25\u91cd\u5e76\u53d1\u75c7\u3002.<\/p>\n

\u8fd1\u5e74\u6765\uff0c\u03b2-\u5730\u4e2d\u6d77\u8d2b\u8840\u7684\u6cbb\u7597\u53d6\u5f97\u4e86\u4e00\u4e9b\u8fdb\u5c55\uff1b\u7136\u800c\uff0c\u4ecd\u5b58\u5728\u672a\u88ab\u6ee1\u8db3\u7684\u9700\u6c42\uff0c\u9700\u8981\u8fdb\u4e00\u6b65\u4e86\u89e3\u8be5\u75be\u75c5\u5e76\u5f00\u53d1\u66f4\u591a\u6cbb\u7597\u65b9\u6848\u3002\u76ee\u524d\u5c1a\u65e0\u83b7\u6279\u7684\u03b1-\u5730\u4e2d\u6d77\u8d2b\u8840\u6cbb\u7597\u65b9\u6cd5\u3002.<\/p>\n

\u5173\u4e8e\u9570\u72b6\u7ec6\u80de\u75c5<\/h3>\n

\u9570\u72b6\u7ec6\u80de\u75c5\u662f\u4e00\u79cd\u9057\u4f20\u6027\u7ea2\u7ec6\u80de\u75be\u75c5\uff0c\u5728\u7f8e\u56fd\u548c\u6b27\u76df\u4e94\u56fd\u7ea6\u670912\u4e07\u81f313.5\u4e07\u4eba\u53d7\u5176\u5f71\u54cd\uff0c\u4e16\u754c\u5176\u4ed6\u5730\u533a\u8fd8\u6709\u66f4\u591a\u60a3\u8005\u3002\u9570\u72b6\u7ec6\u80de\u75c5\u662f\u7531\u4e00\u79cd\u7a81\u53d8\u7684\u8840\u7ea2\u86cb\u767d\u5f15\u8d77\u7684\uff0c\u8fd9\u79cd\u7a81\u53d8\u7684\u8840\u7ea2\u86cb\u767d\u4f1a\u963b\u585e\u8840\u7ba1\u3002\u56e0\u6b64\uff0c\u8840\u6db2\u65e0\u6cd5\u6b63\u5e38\u6d41\u52a8\uff0c\u8fd9\u53ef\u80fd\u5bfc\u81f4\u5267\u70c8\u75bc\u75db\u548c\u5668\u5b98\u635f\u4f24\u3002.<\/p>\n

\u9570\u72b6\u7ec6\u80de\u75c5\u4f1a\u5f15\u53d1\u591a\u79cd\u4e25\u91cd\u5e76\u53d1\u75c7\uff0c\u5305\u62ec\u611f\u67d3\u3001\u6025\u6027\u80f8\u75db\u7efc\u5408\u5f81\u548c\u4e2d\u98ce\uff0c\u5e76\u53ef\u80fd\u5bfc\u81f4\u9884\u671f\u5bff\u547d\u7f29\u77ed\u3002\u5c3d\u7ba1\u8fd1\u5e74\u6765\u7814\u7a76\u548c\u4e34\u5e8a\u8fdb\u5c55\u53d6\u5f97\u4e86\u663e\u8457\u6210\u6548\uff0c\u76ee\u524d\u5df2\u6709\u591a\u79cd\u6cbb\u7597\u65b9\u6848\u53ef\u4f9b\u9009\u62e9\uff1b\u7136\u800c\uff0c\u60a3\u8005\u4ecd\u7136\u9971\u53d7\u6025\u6027\u548c\u6162\u6027\u75bc\u75db\u4ee5\u53ca\u4e25\u91cd\u5e76\u53d1\u75c7\u7684\u56f0\u6270\uff0c\u56e0\u6b64\u4e9f\u9700\u8fdb\u4e00\u6b65\u7684\u6cbb\u7597\u7a81\u7834\u3002.<\/p>\n

\u5173\u4e8ePK\u7f3a\u4e4f\u75c7<\/h3>\n

\u4e19\u916e\u9178\u6fc0\u9176\uff08PK\uff09\u7f3a\u4e4f\u75c7\u662f\u4e00\u79cd\u7f55\u89c1\u7684\u9057\u4f20\u6027\u75be\u75c5\uff0c\u8868\u73b0\u4e3a\u6162\u6027\u6eb6\u8840\u6027\u8d2b\u8840\uff0c\u5373\u7ea2\u7ec6\u80de\u52a0\u901f\u7834\u574f\u3002PKLR\u57fa\u56e0\u7684\u9057\u4f20\u7a81\u53d8\u5bfc\u81f4\u7ea2\u7ec6\u80de\u5185\u7ec6\u80de\u80fd\u91cf\u4e0d\u8db3\uff0c\u8868\u73b0\u4e3aPKR\u9176\u6d3b\u6027\u964d\u4f4e\u3001\u4e09\u78f7\u9178\u817a\u82f7\uff08ATP\uff09\u6c34\u5e73\u4e0b\u964d\u4ee5\u53ca\u4e0a\u6e38\u4ee3\u8c22\u7269\uff08\u5305\u62ec2,3-\u4e8c\u78f7\u9178\u7518\u6cb9\u9178\uff082,3-DPG\uff09\uff09\u7684\u79ef\u7d2f\u3002.<\/p>\n

\u5728\u7f8e\u56fd\u548c\u6b27\u76df5\u56fd\uff0c\u5927\u7ea6\u67093000-8000\u4eba\u60a3\u6709PK\u7f3a\u4e4f\u75c7\u3002PK\u7f3a\u4e4f\u75c7\u53ef\u80fd\u5bfc\u81f4\u4e25\u91cd\u7684\u5e76\u53d1\u75c7\uff0c\u5982\u80ba\u52a8\u8109\u9ad8\u538b\u3001\u9ad3\u5916\u9020\u8840\u548c\u9aa8\u8d28\u758f\u677e\u75c7\u3002.<\/p>\n

\u76ee\u524d\u5c1a\u65e0\u83b7\u6279\u7684PK\u7f3a\u4e4f\u75c7\u75be\u75c5\u6539\u5584\u7597\u6cd5\u3002.<\/p>\n

\u5982\u9700\u4e86\u89e3\u66f4\u591a\u5173\u4e8e\u6b63\u5728\u8fdb\u884c\u7684\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4fe1\u606f<\/a><\/p>\n

\u5173\u4e8e\u963f\u5409\u5965\u65af<\/h3>\n

Agios \u81f4\u529b\u4e8e\u901a\u8fc7\u5728\u7ec6\u80de\u4ee3\u8c22\u9886\u57df\u7684\u79d1\u5b66\u9886\u5148\u5730\u4f4d\uff0c\u53d1\u73b0\u548c\u5f00\u53d1\u7528\u4e8e\u6cbb\u7597\u57fa\u56e0\u76f8\u5173\u75be\u75c5\u7684\u65b0\u578b\u7814\u7a76\u6027\u836f\u7269\u3002\u516c\u53f8\u76ee\u524d\u6700\u5148\u8fdb\u7684\u5019\u9009\u836f\u7269\u662f\u9996\u521b\u7684\u4e19\u916e\u9178\u6fc0\u9176 R (PKR) \u6fc0\u6d3b\u5242 mitapivat\uff0c\u76ee\u524d\u6b63\u5728\u8bc4\u4f30\u5176\u6cbb\u7597\u4e09\u79cd\u4e0d\u540c\u6eb6\u8840\u6027\u8d2b\u8840\u7684\u7597\u6548\u3002\u9664\u4e86\u6d3b\u8dc3\u7684\u540e\u671f\u4e34\u5e8a\u7814\u53d1\u7ba1\u7ebf\u5916\uff0cAgios \u8fd8\u62e5\u6709\u591a\u4e2a\u5904\u4e8e\u4e34\u5e8a\u548c\u4e34\u5e8a\u524d\u5f00\u53d1\u9636\u6bb5\u7684\u65b0\u578b\u7814\u7a76\u6027\u7597\u6cd5\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee[\u6b64\u5904\u63d2\u5165\u94fe\u63a5]\u3002 \u516c\u53f8\u7f51\u7ad9<\/a>.<\/p>\n

\u5173\u4e8e CENTOGENE<\/h4>\n

CENTOGENE\u81f4\u529b\u4e8e\u7f55\u89c1\u75c5\u7684\u8bca\u65ad\u548c\u7814\u7a76\uff0c\u901a\u8fc7\u8f6c\u5316\u771f\u5b9e\u4e16\u754c\u7684\u4e34\u5e8a\u3001\u9057\u4f20\u548c\u591a\u7ec4\u5b66\u6570\u636e\uff0c\u5b9e\u73b0\u7f55\u89c1\u75c5\u7684\u8bca\u65ad\u3001\u7406\u89e3\u548c\u6cbb\u7597\u3002\u6211\u4eec\u7684\u76ee\u6807\u662f\u5229\u7528\u6211\u4eec\u4e30\u5bcc\u7684\u7f55\u89c1\u75c5\u77e5\u8bc6\u548c\u6570\u636e\uff0c\u4e3a\u6cbb\u7597\u51b3\u7b56\u63d0\u4f9b\u5408\u7406\u7684\u4f9d\u636e\uff0c\u5e76\u52a0\u901f\u65b0\u578b\u5b64\u513f\u836f\u7684\u7814\u53d1\u3002CENTOGENE\u5df2\u5f00\u53d1\u51fa\u4e00\u4e2a\u5168\u7403\u4e13\u6709\u7684\u7f55\u89c1\u75c5\u5e73\u53f0\uff0c\u8be5\u5e73\u53f0\u57fa\u4e8e\u6211\u4eec\u62e5\u6709\u8d85\u8fc739\u4ebf\u4e2a\u52a0\u6743\u6570\u636e\u70b9\u7684\u771f\u5b9e\u4e16\u754c\u6570\u636e\u5b58\u50a8\u5e93\uff0c\u8fd9\u4e9b\u6570\u636e\u70b9\u6765\u81ea\u7ea660\u4e07\u540d\u60a3\u8005\uff0c\u6db5\u76d6120\u591a\u4e2a\u56fd\u5bb6\u3002.<\/p>\n

\u516c\u53f8\u5e73\u53f0\u5305\u542b\u53cd\u6620\u5168\u7403\u4eba\u7fa4\u7684\u6d41\u884c\u75c5\u5b66\u3001\u8868\u578b\u548c\u9057\u4f20\u6570\u636e\uff0c\u4ee5\u53ca\u60a3\u8005\u8840\u6db2\u6837\u672c\u548c\u7ec6\u80de\u57f9\u517b\u7269\u7684\u751f\u7269\u6837\u672c\u5e93\u3002CENTOGENE \u8ba4\u4e3a\uff0c\u8fd9\u662f\u76ee\u524d\u552f\u4e00\u4e13\u6ce8\u4e8e\u5bf9\u591a\u5c42\u6b21\u6570\u636e\u8fdb\u884c\u5168\u9762\u5206\u6790\u4ee5\u589e\u8fdb\u5bf9\u7f55\u89c1\u9057\u4f20\u75be\u75c5\u7406\u89e3\u7684\u5e73\u53f0\u3002\u8be5\u5e73\u53f0\u80fd\u591f\u66f4\u597d\u5730\u8bc6\u522b\u548c\u5206\u5c42\u60a3\u8005\u53ca\u5176\u6f5c\u5728\u75be\u75c5\uff0c\u4ece\u800c\u4fc3\u8fdb\u548c\u52a0\u901f\u5b64\u513f\u836f\u7684\u53d1\u73b0\u3001\u5f00\u53d1\u548c\u5e94\u7528\u3002\u622a\u81f3 2020 \u5e74 12 \u6708 31 \u65e5\uff0c\u516c\u53f8\u5df2\u4e0e 30 \u591a\u5bb6\u5236\u836f\u516c\u53f8\u5f00\u5c55\u5408\u4f5c\u3002.<\/p>\n

\u5173\u6ce8\u6211\u4eec \u53fd\u53fd\u55b3\u55b3 <\/a>| Facebook <\/a>| LinkedIn <\/a>| YouTube<\/a><\/p>\n

\u524d\u77bb\u6027\u58f0\u660e<\/h4>\n

\u672c\u65b0\u95fb\u7a3f\u5305\u542b\u7f8e\u56fd\u8054\u90a6\u8bc1\u5238\u6cd5\u610f\u4e49\u4e0a\u7684\u201c\u524d\u77bb\u6027\u9648\u8ff0\u201d\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u975e\u5386\u53f2\u4e8b\u5b9e\u7684\u9648\u8ff0\u5747\u4e3a\u524d\u77bb\u6027\u9648\u8ff0\uff0c\u8bf8\u5982\u201c\u9884\u671f\u201d\u3001\u201c\u76f8\u4fe1\u201d\u3001\u201c\u7ee7\u7eed\u201d\u3001\u201c\u671f\u671b\u201d\u3001\u201c\u4f30\u8ba1\u201d\u3001\u201c\u6253\u7b97\u201d\u3001\u201c\u9884\u8ba1\u201d\u7b49\u8bcd\u8bed\u4ee5\u53ca\u7c7b\u4f3c\u8868\u8fbe\u548c\u8868\u793a\u5c06\u6765\u65f6\u6216\u6761\u4ef6\u7684\u52a8\u8bcd\uff0c\u4f8b\u5982\u201c\u5c06\u201d\u3001\u201c\u4f1a\u201d\u3001\u201c\u5e94\u8be5\u201d\u3001\u201c\u53ef\u80fd\u201d\u3001\u201c\u6216\u8bb8\u201d\u3001\u201c\u53ef\u4ee5\u201d\u7b49\uff0c\u901a\u5e38\u7528\u4e8e\u8bc6\u522b\u524d\u77bb\u6027\u9648\u8ff0\u3002\u6b64\u7c7b\u524d\u77bb\u6027\u9648\u8ff0\u6d89\u53ca\u5df2\u77e5\u548c\u672a\u77e5\u7684\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u4ee5\u53ca\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\uff0c\u8fd9\u4e9b\u56e0\u7d20\u53ef\u80fd\u5bfc\u81f4CENTOGENE\u7684\u5b9e\u9645\u4e1a\u7ee9\u3001\u8868\u73b0\u6216\u6210\u5c31\u4e0e\u524d\u77bb\u6027\u9648\u8ff0\u4e2d\u660e\u793a\u6216\u6697\u793a\u7684\u4efb\u4f55\u672a\u6765\u4e1a\u7ee9\u3001\u8868\u73b0\u6216\u6210\u5c31\u5b58\u5728\u91cd\u5927\u5dee\u5f02\u3002\u6b64\u7c7b\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\u5305\u62ec\u4f46\u4e0d\u9650\u4e8e\uff1a\u5168\u7403\u7ecf\u6d4e\u5f62\u52bf\u6076\u5316\u4ee5\u53ca\u5168\u7403\u91d1\u878d\u5e02\u573a\u6301\u7eed\u4e0d\u7a33\u5b9a\u548c\u6ce2\u52a8\uff1b\u65b0\u51a0\u75ab\u60c5\u5bf9\u6211\u4eec\u7684\u4e1a\u52a1\u548c\u7ecf\u8425\u4e1a\u7ee9\u7684\u5f71\u54cd\uff1b\u73b0\u884c\u548c\u62df\u8bae\u7684\u6cd5\u5f8b\u3001\u6cd5\u89c4\u548c\u653f\u5e9c\u653f\u7b56\u53ef\u80fd\u53d1\u751f\u7684\u53d8\u5316\uff1b\u884c\u4e1a\u7ade\u4e89\u52a0\u5267\u548c\u6574\u5408\u5e26\u6765\u7684\u538b\u529b\uff1b\u76d1\u7ba1\u5ba1\u6279\uff08\u5305\u62ec\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u7684\u5ba1\u6279\uff09\u7684\u8d39\u7528\u548c\u4e0d\u786e\u5b9a\u6027\uff1b\u6211\u4eec\u5bf9\u7b2c\u4e09\u65b9\u548c\u5408\u4f5c\u4f19\u4f34\u7684\u4f9d\u8d56\uff08\u5305\u62ec\u6211\u4eec\u7ba1\u7406\u589e\u957f\u548c\u5efa\u7acb\u65b0\u5ba2\u6237\u5173\u7cfb\u7684\u80fd\u529b\uff09\uff1b\u6211\u4eec\u5bf9\u7f55\u89c1\u75c5\u884c\u4e1a\u7684\u4f9d\u8d56\uff1b\u6211\u4eec\u7ba1\u7406\u56fd\u9645\u6269\u5f20\u7684\u80fd\u529b\uff1b\u6211\u4eec\u5bf9\u5173\u952e\u4eba\u5458\u7684\u4f9d\u8d56\uff1b\u6211\u4eec\u5bf9\u77e5\u8bc6\u4ea7\u6743\u4fdd\u62a4\u7684\u4f9d\u8d56\uff1b\u6c47\u7387\u6216\u5176\u4ed6\u56e0\u7d20\u5bfc\u81f4\u7684\u7ecf\u8425\u4e1a\u7ee9\u6ce2\u52a8\u3002\u6709\u5173\u53ef\u80fd\u5bfc\u81f4\u5b9e\u9645\u7ed3\u679c\u4e0e\u8fd9\u4e9b\u524d\u77bb\u6027\u58f0\u660e\u4e2d\u6240\u8868\u8fbe\u7684\u7ed3\u679c\u5b58\u5728\u5dee\u5f02\u7684\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\uff0c\u4ee5\u53ca\u4e0eCENTOGENE\u4e1a\u52a1\u76f8\u5173\u7684\u603b\u4f53\u98ce\u9669\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u53c2\u9605CENTOGENE\u4e8e2021\u5e744\u670815\u65e5\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\uff08\u201cSEC\u201d\uff09\u63d0\u4ea4\u768420-F\u8868\u683c\u53ca\u5176\u540e\u7eed\u6587\u4ef6\u4e2d\u5217\u51fa\u7684CENTOGENE\u98ce\u9669\u56e0\u7d20\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u5305\u542b\u7684\u4efb\u4f55\u524d\u77bb\u6027\u58f0\u660e\u4ec5\u4ee3\u8868\u622a\u81f3\u672c\u65b0\u95fb\u7a3f\u53d1\u5e03\u4e4b\u65e5\u7684\u4fe1\u606f\uff0cCENTOGENE\u660e\u786e\u58f0\u660e\u4e0d\u627f\u62c5\u4efb\u4f55\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u58f0\u660e\u7684\u4e49\u52a1\uff0c\u65e0\u8bba\u662f\u56e0\u4e3a\u65b0\u4fe1\u606f\u3001\u672a\u6765\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u3002.<\/p>\n

\u5a92\u4f53\u8054\u7cfb\u4eba\uff1a<\/h5>\n

\u4e2d\u5fc3\u57fa\u56e0
\u672c\u00b7\u83b1\u683c
\u4f01\u4e1a\u4f20\u64ad\u90e8
Ben.Legg(at)centogene(dot)com<\/a><\/p>\n

\u4f26\u7eb3\u7279\u00b7\u65af\u7279\u8d56\u8d1d\u5c14
\u6295\u8d44\u8005\u5173\u7cfb
investor.relations(at)centogene(dot)com<\/a><\/p>\n

FTI\u54a8\u8be2\u516c\u53f8
\u7f57\u4f2f\u7279\u00b7\u65af\u5766\u5c3c\u65af\u62c9\u7f57
robert.stanislaro(at)fticonsulting(dot)com <\/a><\/p>\n

\u745e\u79cb\u00b7\u514b\u83b1\u66fc
rachel.kleiman(at)fticonsulting(dot)com <\/a><\/p>","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 4, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2247","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nCENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/zh\/centogene\u6269\u5927\u4e0eagios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u89c1\u8840\u6db2\u75be\u75c5\u9886\u57df\u83b7\u5f97\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 4, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/zh\/centogene\u6269\u5927\u4e0eagios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u89c1\u8840\u6db2\u75be\u75c5\u9886\u57df\u83b7\u5f97\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-23T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases\",\"datePublished\":\"2021-11-23T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\"},\"wordCount\":1481,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\",\"name\":\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2021-11-23T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/zh\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE\u6269\u5927\u4e0eAgios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u89c1\u8840\u6db2\u75c5\u9886\u57df\u83b7\u5f97\u65b0\u7684\u89c1\u89e3 | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/zh\/centogene\u6269\u5927\u4e0eagios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u89c1\u8840\u6db2\u75be\u75c5\u9886\u57df\u83b7\u5f97\/","og_locale":"zh_CN","og_type":"article","og_title":"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases | CENTOGENE","og_description":"CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, November 4, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]","og_url":"https:\/\/www.centogene.com\/zh\/centogene\u6269\u5927\u4e0eagios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u89c1\u8840\u6db2\u75be\u75c5\u9886\u57df\u83b7\u5f97\/","og_site_name":"CENTOGENE","article_published_time":"2021-11-23T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"admincg","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"7 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases","datePublished":"2021-11-23T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/"},"wordCount":1481,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/","url":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/","name":"CENTOGENE\u6269\u5927\u4e0eAgios\u7684\u5408\u4f5c\uff0c\u4ee5\u671f\u5728\u7f55\u89c1\u8840\u6db2\u75c5\u9886\u57df\u83b7\u5f97\u65b0\u7684\u89c1\u89e3 | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2021-11-23T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-expands-partnership-with-agios-to-generate-novel-insights-into-rare-blood-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"\u4e2d\u5fc3\u57fa\u56e0","description":"\u6307\u5bfc\u7cbe\u51c6\u533b\u7597","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"\u4e2d\u5fc3\u57fa\u56e0","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"\u7ba1\u7406\u5458","url":"https:\/\/www.centogene.com\/zh\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/posts\/2247","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/comments?post=2247"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/posts\/2247\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/media?parent=2247"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/categories?post=2247"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/zh\/wp-json\/wp\/v2\/tags?post=2247"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}